Article info
Section 2: Selection, procurement and distribution
3PC-071 Fully automated central intravenous additive service (CIVAS): a 12 month analysis of performances and impact of COVID-19 on sterile antibiotic production
Citation
3PC-071 Fully automated central intravenous additive service (CIVAS): a 12 month analysis of performances and impact of COVID-19 on sterile antibiotic production
Publication history
- First published March 14, 2021.
Online issue publication
March 15, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.